The Effect of the Antioxidant (GliSODin) on Unexplained Fatigue
Evaluation of an orally-bioactive form of Superoxide Dismutase, GliSODin, in reducing levels of fatigue in otherwise healthy women aged between 50-65 years over a 12-week period.
Applied Science & Nutrition
40 participants
Jul 1, 2007
Interventional
Conditions
Summary
Fatigue is a common problem and in many cases its cause cannot be medically explained. An understanding of the biochemical processes humans use to generate energy within the cells leads to a hypothesis to explain the cause of some forms of fatigue based on defective cellular energy processes. The active substance used in this study, GliSODin contains Superoxide Dismutase, an enzyme which may assist in the normal biochemical production of energy in human cells.
Eligibility
Inclusion Criteria1
- Unexplained fatigue of greater than 3 months' duration
Exclusion Criteria1
- Clinical Depression, Diagnosed Thyroid Disorder, Iron-deficiency anaemia, Coeliac Disease, Any serious disease, History of Alcohol or Drug Abuse, Primary Sleep Disorder
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Superoxide dismutase enzyme in an orally-bioactive form, 250mg daily for 12 weeks. The capsule contains 3.11mg melon extract in a base of maltodexrtin.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000420448